Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07282769
PHASE2

Semaglutide (Wegovy) Treatment for Trichotillomania

Sponsor: University of Chicago

View on ClinicalTrials.gov

Summary

This research study is testing the effectiveness and safety of semaglutide (Wegovy) in people with trichotillomania, also known as hair-pulling disorder.

Official title: Once Weekly Semaglutide Treatment of Trichotillomania: An Open-Label Study

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

10

Start Date

2026-02

Completion Date

2027-02

Last Updated

2025-12-17

Healthy Volunteers

No

Interventions

DRUG

Semaglutide

All participants in the study will receive semaglutide (Wegovy).